Last month's U.S. Supreme Court decision in Association for Molecular Pathology v. Myriad Genetics, which considered whether portions of human genes may be patented, generated an extraordinary amount of passion for an intellectual property case.
James Watson, the Nobel Laureate credited with discovery of the double helix structure of DNA, wrote an amicus brief opining that human genes should not be patented: "Life's instructions ought not be controlled by legal monopolies created at the whim of Congress or the courts."
